• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型隐球菌的细胞内命运

Intracellular fate of Cryptococcus neoformans.

作者信息

Tacker J R, Farhi F, Bulmer G S

出版信息

Infect Immun. 1972 Aug;6(2):162-7. doi: 10.1128/iai.6.2.162-167.1972.

DOI:10.1128/iai.6.2.162-167.1972
PMID:4569916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC422509/
Abstract

Human peripheral leukocytes were found to engulf and kill cells of Cryptococcus neoformans. Fewer encapsulated than nonencapsulated cells met this fate, since cryptococcal capsular polysaccharide inhibited phagocytosis. During 10 to 12 hr of incubation of nonencapsulated cells in human serum, sufficient polysaccharide was produced to inhibit phagocytosis by 50%. The polysaccharide inhibitor was found in the sera of four patients with cryptococcosis, but not on the surfaces of their leukocytes. Additional experiments indicated that serum is not essential for effective phagocytosis. However, normal human serum contains anticryptococcal activity which is not inhibited by capsular material. Preliminary findings indicate that the phagocytic index of a patient with cryptococcosis may be correlated with the severity of his disease.

摘要

研究发现人类外周血白细胞能够吞噬并杀死新型隐球菌细胞。被吞噬杀死的荚膜型细胞比非荚膜型细胞少,因为隐球菌荚膜多糖会抑制吞噬作用。在人血清中对非荚膜型细胞进行10至12小时的孵育后,会产生足够的多糖,使吞噬作用受到50%的抑制。在四名隐球菌病患者的血清中发现了多糖抑制剂,但在他们白细胞的表面未发现。进一步的实验表明,血清并非有效吞噬作用所必需。然而,正常人血清含有抗隐球菌活性,且不受荚膜物质的抑制。初步研究结果表明,隐球菌病患者的吞噬指数可能与其疾病严重程度相关。

相似文献

1
Intracellular fate of Cryptococcus neoformans.新型隐球菌的细胞内命运
Infect Immun. 1972 Aug;6(2):162-7. doi: 10.1128/iai.6.2.162-167.1972.
2
Cryptococcus neoformans. 3. Inhibition of phagocytosis.新型隐球菌。3. 吞噬作用的抑制。
J Bacteriol. 1968 Jan;95(1):5-8. doi: 10.1128/jb.95.1.5-8.1968.
3
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.新型隐球菌的非包膜变种。II. 隐球菌多糖的表面受体及其在多糖抑制吞噬作用中的作用。
Infect Immun. 1977 Apr;16(1):99-106. doi: 10.1128/iai.16.1.99-106.1977.
4
Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.疏水性表面与荚膜型和非荚膜型新型隐球菌吞噬作用的解离
Infect Immun. 1983 Mar;39(3):1214-9. doi: 10.1128/iai.39.3.1214-1219.1983.
5
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.隐球菌多糖与新型隐球菌的结合。
Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984.
6
Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.血清因子在豚鼠外周血白细胞对轻度或重度荚膜化新型隐球菌菌株的吞噬作用中的作用。
Microbiol Immunol. 1984;28(1):51-61. doi: 10.1111/j.1348-0421.1984.tb02946.x.
7
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.隐球菌多糖的表面电荷与吞噬作用抑制之间存在伴随但非因果的关联。
Infect Immun. 1980 Aug;29(2):295-300. doi: 10.1128/iai.29.2.295-300.1980.
8
Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.人免疫球蛋白G对新型隐球菌的调理作用:隐球菌多糖对免疫球蛋白G的掩盖作用
Infect Immun. 1979 Jul;25(1):262-7. doi: 10.1128/iai.25.1.262-267.1979.
9
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.新型隐球菌。二、人类白细胞的吞噬作用。
J Bacteriol. 1967 Nov;94(5):1480-3. doi: 10.1128/jb.94.5.1480-1483.1967.
10
Phagocytosis of Cryptococcus neoformans by alveolar macrophages.肺泡巨噬细胞对新型隐球菌的吞噬作用。
Infect Immun. 1975 Jan;11(1):73-9. doi: 10.1128/iai.11.1.73-79.1975.

引用本文的文献

1
Alternatively activated lung alveolar and interstitial macrophages promote fungal growth.交替活化的肺泡和间质巨噬细胞促进真菌生长。
iScience. 2023 Apr 23;26(5):106717. doi: 10.1016/j.isci.2023.106717. eCollection 2023 May 19.
2
The Transcription Factor Pdr802 Regulates Titan Cell Formation and Pathogenicity of Cryptococcus neoformans.转录因子 Pdr802 调控新生隐球菌泰坦细胞的形成和致病性。
mBio. 2021 Mar 9;12(2):e03457-20. doi: 10.1128/mBio.03457-20.
3
Mechanisms of fungal dissemination.真菌传播的机制。
Cell Mol Life Sci. 2021 Apr;78(7):3219-3238. doi: 10.1007/s00018-020-03736-z. Epub 2021 Jan 15.
4
Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.中性粒细胞与新型隐球菌相互作用的实时成像显示补体C5a - C5aR信号传导的关键作用。
Infect Immun. 2015 Oct 26;84(1):216-29. doi: 10.1128/IAI.01197-15. Print 2016 Jan.
5
Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.新型隐球菌中SKN7同源物的鉴定与表征
Infect Immun. 2005 Aug;73(8):5022-30. doi: 10.1128/IAI.73.8.5022-5030.2005.
6
A yeast under cover: the capsule of Cryptococcus neoformans.隐藏在酵母之下:新型隐球菌的荚膜
Eukaryot Cell. 2003 Aug;2(4):655-63. doi: 10.1128/EC.2.4.655-663.2003.
7
Isolation and characterization of the Cryptococcus neoformans MATa pheromone gene.新型隐球菌MATa信息素基因的分离与鉴定
Genetics. 2002 Mar;160(3):935-47. doi: 10.1093/genetics/160.3.935.
8
Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans.人中性粒细胞对新型隐球菌的非氧化抗真菌活性。
Infect Immun. 2000 Nov;68(11):6257-64. doi: 10.1128/IAI.68.11.6257-6264.2000.
9
Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.新型隐球菌是小鼠肺部感染中的兼性细胞内病原体。
Infect Immun. 2000 Jul;68(7):4225-37. doi: 10.1128/IAI.68.7.4225-4237.2000.
10
Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.C3a和C5a在人多形核细胞响应新型隐球菌荚膜物质分泌白细胞介素-8中的作用。
Infect Immun. 1998 Sep;66(9):4324-30. doi: 10.1128/IAI.66.9.4324-4330.1998.

本文引用的文献

1
Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.新型隐球菌 IV. 非包裹酵母菌。
Infect Immun. 1970 Jun;1(6):526-31. doi: 10.1128/iai.1.6.526-531.1970.
2
Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum.烟曲霉孢子与人白细胞和血清的相互作用。
Infect Immun. 1970 Apr;1(4):345-50. doi: 10.1128/iai.1.4.345-350.1970.
3
Serologically reactive material in spinal fluid, blood, and urine from a human case of cryptococcosis (torulosis).
Proc Soc Exp Biol Med. 1951 Aug;77(4):775-8. doi: 10.3181/00379727-77-18924.
4
INTRACELLULAR GROWTH OF HISTOPLASMA CAPSULATUM.荚膜组织胞浆菌的细胞内生长
J Bacteriol. 1965 Feb;89(2):518-23. doi: 10.1128/jb.89.2.518-523.1965.
5
BEHAVIOR OF CANDIDA CELLS WITHIN LEUKOCYTES.白色念珠菌细胞在白细胞内的行为
Proc Soc Exp Biol Med. 1964 Jan;115:93-8. doi: 10.3181/00379727-115-28840.
6
CHARACTERIZATION OF THE GROWTH INHIBITION FACTOR FOR CRYPTOCOCCUS NEOFORMANS (GIFC) IN HUMAN SERUM.人血清中新型隐球菌生长抑制因子(GIFC)的特性研究
Am J Med Sci. 1963 Jul;246:53-7. doi: 10.1097/00000441-196307000-00007.
7
Cryptococcus neoformans. I. Nonencapsulated mutants.新型隐球菌。I. 非荚膜突变体。
J Bacteriol. 1967 Nov;94(5):1475-9. doi: 10.1128/jb.94.5.1475-1479.1967.
8
The anticryptococcal factor of blood serum. A preliminary report.血清抗隐球菌因子。初步报告。
J Invest Dermatol. 1966 Mar;46(3):306-8. doi: 10.1038/jid.1966.47.
9
Protein synthesis by phagocytized yeast cells of Histoplasma capsulatum.荚膜组织胞浆菌被吞噬的酵母细胞进行蛋白质合成。
Sabouraudia. 1969 Oct;7(3):186-94.
10
Cryptococcus neoformans. 3. Inhibition of phagocytosis.新型隐球菌。3. 吞噬作用的抑制。
J Bacteriol. 1968 Jan;95(1):5-8. doi: 10.1128/jb.95.1.5-8.1968.